VALN•benzinga•
First Infant Vaccinated in Valneva And LimmaTech's Phase 2 S4V2 Trial, Targeting Global Shigellosis Threat
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 9, 2025 by benzinga